Eukaryotic initiation factor 4A (eIF4A) is a member of the DEAD-box family of putative RNA helicases whose members are involved in many aspects of RNA metabolism. eIF4A is thought to facilitate binding of 43S preinitiation complexes to mRNAs by unwinding secondary structures present in the 5 0 untranslated region. Pateamine A, a small-molecule inhibitor of translation initiation, acts in an unusual manner by stimulating eIF4A activity. Herein, we report the elucidation of pateamine's mode of action. We demonstrate that Pateamine A is a chemical inducer of dimerization that forces an engagement between eIF4A and RNA and prevents eIF4A from participating in the ribosome-recruitment step of translation initiation.
Introduction
The ribosome-recruitment phase of translation initiation in eukaryotes is the rate-limiting step of protein synthesis and a major site of translational control. Eukaryotic initiation factor 4F (eIF4F) plays a critical role in this process and consists of three subunits: eIF4E, a protein that binds mRNA cap structures (m 7 GpppN, where N is any nucleotide) present at the 5 0 end of cellular cytoplasmic mRNAs; eIF4A, an ATP-dependent RNA helicase; and eIF4G, a scaffolding protein that recruits 43S preinitiation complexes through interactions with eIF3. eIF4F is positioned at the 5 0 end of mRNAs by eIF4E, where the eIF4A subunit is thought to unwind the local mRNA secondary structure to facilitate ribosome binding [1] .
eIF4A is a member of the DEAD-box protein family of putative RNA helicases. It exhibits ATP-stimulated RNA binding, RNA-dependent ATPase, and helicase activities [2] . eIF4A can exist as a free form (eIF4A f ) and as a subunit of eIF4F (eIF4A c ), and it is thought to recycle through the eIF4F complex during translation initiation [3, 4] . eIF4A f is incorporated into the eIF4F complex via its interaction with eIF4G, which contains two eIF4A-binding sites [5] [6] [7] [8] . One site is located in the middle domain of eIF4G and is believed to stabilize RNA binding to eIF4A [9] , whereas the other is present within the C-terminal domain of eIF4G and is thought to play a modulatory role in translation [5] [6] [7] [8] 10] . eIF4G was hypothesized to act as a clamp that stabilizes the closed ''active'' conformation of eIF4A [11] . This is consistent with the observation that the helicase activity of eIF4A c is w20-fold more efficient than that of eIF4A f , and that the middle domain of eIF4G is capable of stimulating eIF4A ATPase activity [9, 12, 13] .
The related RNA-binding proteins, eIF4B and eIF4H, also modulate eIF4A activity by increasing its RNA-binding affinity [2, 14] . eIF4B possesses an RNA recognition motif (RRM) in its N-terminal domain and an argininerich domain at its C terminus [15, 16] . The RRM can bind 18S rRNA, while the arginine-rich domain binds RNA in a non-sequence-dependent fashion [17] . The mechanistic details of how eIF4B affects eIF4A RNAbinding activity have not been characterized, but it appears that both RNA-binding domains of eIF4B are required [15] . A direct interaction between eIF4A and eIF4B has not been previously reported [15] , although interaction between eIF4H and eIF4A has been documented [18] (A. Marintchev and G.W., unpublished data).
Pateamine A (PatA) is a small-molecule modulator of eIF4A activity recently identified as a potent inhibitor of translation [19, 20] (Figure 1A ). PatA stimulates eIF4A-associated activities, but the mechanism by which it inhibits protein synthesis is not well understood. Low et al. [20] reported that this compound promotes an association between eIF4A and eIF4B, although affinity chromatography experiments with immobilized PatA have documented retention of only eIF4A, and not of eIF4B [19] . In an attempt to clarify PatA's mechanism of action, we examined its effects on association between eIF4A and eIF4B, eIF4B and RNA, and eIF4A and eIF4G. We found that eIF4A and eIF4B do not directly associate in the presence of PatA, but rather that the apparent interaction between eIF4A and eIF4B in the presence of PatA is indirect and RNA dependent. Our results indicate that PatA inhibits translation by causing eIF4A to be sequestered on RNA, thus limiting its availability for incorporation into the eIF4F complex. To our knowledge, PatA is the first example of a chemical inducer of dimerization that forces an engagement between a translation factor and RNA, thus preventing eIF4A from participating in translation initiation.
Results and Discussion
PatA Causes RNA-Dependent Copurification of eIF4A and eIF4B We suspected that the PatA-induced association between eIF4A and eIF4B previously reported [20] might be indirectly mediated by RNA, since both proteins bind RNA and PatA stimulates eIF4A RNA-binding *Correspondence: jerry.pelletier@mcgill.ca activity [19] . To experimentally address this, we performed GST affinity capture experiments with purified recombinant proteins in which eIF4A-GST, His 6 -eIF4B, and poly(U) were incubated in the presence or absence of PatA (Figure 1 ). The resulting complexes were then purified using glutathione beads and characterized by western blotting. An interaction between eIF4A-GST and His 6 -eIF4B was not detected in the presence or absence of PatA when RNA was omitted from the binding reactions ( Figure 1B, lanes 1 and 2) . PatA caused His 6 -eIF4B to copurify with eIF4A-GST only when poly(U) RNA was present ( Figure 1B , compare lane 6 to lane 5). His 6 -eIF4B did not associate nonspecifically with the glutathione resin, either in the absence ( Figure 1B , lanes 3 and 4) or presence ( Figure 1B , lanes 7 and 8) of RNA. These results suggest that the PatA-induced association between eIF4A-GST and His 6 -eIF4B is RNA mediated. This was confirmed by the addition of RNase A to binding reactions prior to affinity capture, which abrogated copurification of eIF4A-GST and His 6 -eIF4B ( Figure 1C , compare lanes 3 and 4 to lanes 1 and 2).
We tested different RNA species for their ability to mediate PatA's effect and found that whereas poly(U) RNA (200 nucleotides long, on average [M.-E.B., unpublished data]) was able to support copurification of eIF4A-GST and His 6 -eIF4B in the presence of PatA, an 11 nucleotide long RNA (termed RNA-11) could not ( Figure 1D , compare lanes 1 and 2 to lanes 3 and 4). Preincubation of (B) eIF4A and eIF4B copurify in the presence of PatA and RNA. His 6 -eIF4B was incubated with eIF4A-GST in the presence of 0.5% DMSO (lanes 1, 3, 5, and 7) or 10 mM PatA (lanes 2, 4, 6, and 8). Poly(U) RNA was added where indicated. eIF4A-GST was purified using glutathione beads, and eluted proteins were subjected to SDS-PAGE and probed by western blotting using a-eIF4A (top panel) and a-eIF4B (bottom panel) antibodies. Lane 9 (bottom panel) illustrates the quality of the input recombinant eIF4B preparation used in this experiment; asterisks denote degradation products. (C) RNase A treatment abolishes PatA-induced eIF4A:eIF4B copurification. Recombinant His 6 -eIF4B was incubated with eIF4A-GST in the presence of poly(U) RNA and either 0.5% DMSO (lanes 1 and 3) or 10 mM PatA (lanes 2 and 4). RNase A was added where indicated (lanes 3 and 4). Complexes were purified, and proteins were resolved and visualized as described in (A). (D) The RNA-mediated association of eIF4B and eIF4A in the presence of PatA is RNA length dependent. His 6 -eIF4B was incubated with eIF4A-GST in the presence of 0.5% DMSO (lanes 1 and 3) or 10 mM PatA (lanes 2 and 4) and either poly(U) RNA (lanes 1 and 2) or RNA-11 (lanes 3 and 4). Complexes were purified, and proteins were resolved and visualized as described in (A). (E) Competition by RNA-11 eliminates copurification of eIF4A and eIF4B in the presence of PatA and poly(U). His 6 -eIF4B was incubated with eIF4A-GST in the presence of poly(U) RNA, 0.5% DMSO or 10 mM PatA, and the indicated concentrations of RNA-11. Complexes were purified, and proteins were resolved and visualized as described in (A).
eIF4A-GST with RNA-11 prior to the addition of His 6 -eIF4B and poly(U) decreased the amount of His 6 -eIF4B copurifying with eIF4A-GST in this pull-down assay ( Figure 1E , compare lanes 6 and 4 to lane 2). We rationalize that this is a consequence of RNA-11 competing out an association between eIF4A-GST or His 6 -eIF4B and poly(U), thereby inhibiting the RNA-mediated copurification of eIF4A-GST and His 6 -eIF4B. This suggested to us that PatA does not directly promote the binding of eIF4B to eIF4A, but rather facilitates the copurification of eIF4A and eIF4B by stimulating the ability of eIF4A to nonspecifically interact with RNA.
We have previously shown that PatA stimulates the RNA-binding activity of eIF4A in an ATP-independent fashion [19] . To determine if PatA affects eIF4B RNAbinding properties, we examined the effects of PatA on the crosslinking of His 6 -eIF4B to mRNA ( Figure 2 ). PatA did not significantly stimulate the binding of recombinant His 6 -eIF4B to b-globin mRNA (Figure 2A , compare lane 2 to lane 1). Since eIF4A is known to stimulate the RNAbinding activity of eIF4B [15, 21] , we monitored whether the PatA-stimulated binding of eIF4A to RNA would exert an effect on eIF4B RNA-binding properties ( Figure 2B ). PatA caused a 5-fold increase in the amount of eIF4A crosslinking to RNA, whereas only a slight effect on eIF4B RNA-binding activity was detected (1.5-fold increase) ( Figure 2B , compare lane 2 to lane 1). These data suggest that PatA does not exert a significant effect on the RNA-binding properties of recombinant eIF4B.
PatA Causes Copurification of eIF4A and Other RNA-Binding Proteins If the PatA-induced association between eIF4A and eIF4B is an indirect consequence of a forced engagement between eIF4A and RNA caused by PatA, then PatA should facilitate copurification of other RNA-binding proteins with eIF4A in the presence of RNA. We therefore performed GST affinity capture experiments with eIF4A and YB-1, a nucleic acid-binding protein that is a major structural component of mRNP complexes and also a regulator of translation [22] . We first tested if PatA is able to alter the ability of YB-1 to bind RNA, and we found that PatA has no effect on the RNA-binding activity of recombinant YB-1 ( Figure 3A , compare lane 2 to lane 1). We then performed GST affinity capture experiments with eIF4A-GST and YB-1 and observed that PatA facilitates copurification of YB-1 and eIF4A in the presence of poly(A)+ mRNA ( Figure 3B , compare lane 2 to lane 1). The ability of PatA to mediate RNAdependent copurification of eIF4A with other RNAbinding proteins is consistent with our previous observation that PatA stimulates the RNA-binding activity of eIF4A [19] .
PatA Inhibits 48S Complex Formation and the Incorporation of eIF4A into the eIF4F Complex
We previously reported that PatA inhibits 48S complex formation on a CAT reporter mRNA [19] . In contrast, it has been shown that PatA does not inhibit 48S complex formation but causes stalling of 48S initiation complexes on globin mRNA [20] . Given that different mRNAs were used in the two studies, and that variations in the amount of secondary structure in the 5 0 UTR of mRNAs are known to alter eIF4A dependency for translation [23] , we assessed the effect of PatA on initiation complex formation on b-globin mRNA. Similarly to what we previously observed for CAT mRNA [19] , PatA inhibited 48S complex formation on b-globin mRNA at 10 mM ( Figure 4A ). The reasons for the discrepancy between the two studies is not immediately apparent but may relate to the fact that our PatA preparation was isolated from the Mycale sponge [19] , whereas the one used by Low et al. was of . After nuclease digestion, samples were resolved on SDS-PAGE gels that were dried and subjected to autoradiography. Asterisks denote degradation products in the YB-1 preparation. (B) eIF4A and YB-1 copurify in the presence of PatA and RNA. Recombinant YB-1 was incubated with eIF4A-GST and poly(A)+ mRNA in the presence of 0.5% DMSO (lane1) or 10 mM PatA (lane 2). eIF4A-GST was purified using glutathione beads, and eluted proteins were subjected to SDS-PAGE and western blotting using a-eIF4A (top panel) and a-YB-1 (bottom panel) antibodies. Lane 3 illustrates the quality of the input recombinant YB-1 preparation used in this experiment.
synthetic origin [20] . Our results are consistent with in vitro reconstitution experiments demonstrating that eIF4A is indispensable for ribosome loading onto mRNAs containing even a modest amount of secondary structure [24] .
We next addressed whether the ability of PatA to stimulate the RNA-binding activity of eIF4A could cause a reduction in the amount of eIF4A available to assemble into the eIF4F complex. This could provide an explanation for the observed decrease in 48S complex formation noted above. We therefore performed m 7 GTP affinity capture experiments in which recombinant His 6 -eIF4A was incubated with initiation factor preparations (ribosomal high-salt wash) in the presence or absence of PatA. Incorporation of His 6 -eIF4A into the eIF4F complex was monitored by purifying the complexes on an m 7 GTP affinity resin and analyzing the GDP and m 7 GDP eluents for the presence of eIF4E, His 6 -eIF4A, and eIF4G ( Figure 4B ). PatA caused a reduction in the amount of His 6 -eIF4A associated with eIF4F, whereas eIF4E or eIF4G levels were not affected ( Figure 4B , compare lane 4 to lane 2). These results are consistent with those of Low et al. [20] , who documented reduced levels of eIF4AI in the eIF4F complex in the presence of PatA.
PatA Induces RNA-Mediated Sequestration of eIF4A from eIF4G The observation that PatA reduces the amount of eIF4A in the eIF4F complex suggests that it may directly interfere with binding of eIF4A to eIF4G. We therefore assessed if PatA inhibits the eIF4A:eIF4G interaction by performing GST affinity capture experiments with His 6 -eIF4A and two GST-tagged eIF4GI fragments spanning the individual eIF4A-binding sites ( Figure 5A ) [5] [6] [7] [8] . PatA did not inhibit the association of eIF4A with either eIF4GI 688-1023 or eIF4GI 1203-1600 ( Figure 5B , compare lane 3 to lane 2 and lane 6 to lane 5). No eIF4A was retained on the glutathione resin in the absence of either GST-eIF4GI fragment ( Figure 5B, lanes 1 and 4) . To confirm these results, we used an independent time-resolved fluorescence resonance energy transfer assay that monitors the eIF4AI:eIF4GI interaction in a homogenous format ( Figure 5C ). The signal-to-background (S/B) ratio in this assay indicates that PatA neither significantly inhibits nor stimulates the interaction between His 6 -eIF4A and either GST-eIF4GI or GST-eIF4GI 1203-1600 ( Figure 5C ). Although, eIF4GI and eIF4GII are only 46% similar, they contain homologous protein-binding domains and interact with the same factor set to form functional eIF4F complexes [25] . We therefore tested whether the interaction between eIF4GII and eIF4AI is affected by PatA ( Figure 5D ). In this analysis, addition of PatA to the middle domain of eIF4GII (eIF4GII-m, residues 745-1003) did not cause a change in NMR chemical shifts on uniformly labeled eIF4GII-m ( Figure 5D, left panel) . Addition of eIF4AI to eIF4GII-m showed substantial chemical shift changes for resonance signals of eIF4GII-m that were unaltered by the presence of PatA, indicating that PatA does not cause the eIF4GII-m:eIF4AI complex to dissociate (Figure 5D, right panel) .
Our previous inability to detect copurification of eIF4E and eIF4G with eIF4A on a PatA affinity matrix indicates that only eIF4A f is bound by PatA [19] (M.-E.B., unpublished data). This suggests a model whereby PatA stimulates the non-sequence-dependent binding of eIF4A to mRNA, causing a global reduction in eIF4A f levels available for incorporation into the eIF4F complex. One prediction from this model is that eIF4G should not copurify with eIF4A when eIF4A is induced to bind RNA Initiation factor preparations were supplemented with recombinant His 6 -eIF4A and were incubated with 0.5% DMSO or 10 mM PatA. eIF4F was purified by m 7 GTP chromatography. The GDP and m 7 GDP eluents were probed by western blotting for the presence of recombinant His 6 -eIF4A, endogenous eIF4E, and eIF4GI.
in the presence of PatA. To experimentally address this, we performed affinity capture experiments in which His 6 -eIF4A and GST-eIF4GI fragments were incubated with or without PatA in the presence of poly(U) Sepharose. In the absence of His 6 -eIF4A, GST-eIF4GI 688-1023 was retained on the poly(U) beads ( Figure 6A, bottom panel, lanes 1  and 2) , an occurrence that is likely a consequence of this fragment harboring an RNA-binding site (see Figure 5A ), whereas GST-eIF4G 1203-1600 was not, due to the lack of an RNA-binding motif ( Figure 6A , bottom panel, lanes 5 and 6). Some His 6 -eIF4A was pulled down by the poly(U) beads, and a concomitant increase in the amount of GST-eIF4GI 688-1023 or GST-eIF4GI 1203-1600 copurifying was noted ( Figure 6A , bottom panel, compare lanes 3 and 7 to lanes 1 and 5, respectively). PatA stimulated the binding of His 6 -eIF4A to the poly(U) affinity resin without causing an equivalent increase in the amount of GST-eIF4GI 688-1023 or GST-eIF4GI 1203-1600 being captured ( Figure 6A , compare lane 4 to lane 3 and lane 8 to lane 7). These results suggest that PatA does not cause sequestration of eIF4G with RNA-bound eIF4A.
We next assessed whether PatA could cause a similar sequestration of eIF4A in vivo. We exposed cells to PatA and observed a disruption of polysomes, as previously reported ( Figure 6B ) [19] . We then probed fractions from the polysome gradients to determine the extent of sedimentation of eIF4A, eIF4E, and eIF4GI ( Figure 6C ). PatA caused eIF4A to cosediment into heavier complexes, consistent with PatA stimulating the RNA binding activity of eIF4A. To demonstrate that the change in the eIF4A sedimentation profile in the presence of PatA was mediated by the stimulation of eIF4A RNA-binding activity, we treated an aliquot of the cell extract prepared from PatA-exposed cells with nuclease prior to centrifugation ( Figure 6B ). This caused eIF4A to be released from heavier sedimenting complexes and regain a sedimentation profile similar to that observed with extracts prepared from untreated cells ( Figure 6C ). The sedimentation profile of eIF4E and eIF4GI remained unchanged in the presence or absence of PatA, consistent with our proposal that eIF4F complexes are not sequestered by RNA-bound eIF4A.
Although eIF4A is very abundant (three copies/ribosome) [26] , its delivery to mRNA is mediated by eIF4F [3, 4] , providing a mechanism that ensures coupling of RNA unwinding with ribosome recruitment. The results presented here suggest a model whereby RNA mediates PatA's inhibition of translation by titrating eIF4A away from the translation apparatus, rendering it unavailable to participate in the initiation phase (Figure 7 ). This would reduce the levels of eIF4A available for recycling into the eIF4E:eIF4G complex (Figure 7 ). eIF4F complexes devoid of eIF4A cannot recruit 43S preinitiation complexes on mRNAs [12, 24] , thereby imposing a block at the initiation level. The regulation of translation initiation by non-sequence-selective sequestration of eIF4A (and PABP) to a small brain-specific noncoding RNA, BC1, at synaptodendritic microdomains is a well-described mechanism for repressing translation [27, 28] . To our knowledge, our results define a novel mechanism by which translation initiation is targeted by a small molecule acting as a chemical inducer of dimerization that forces the engagement between eIF4A f and RNA.
Significance RNA helicases are molecular motors involved in virtually all aspects of RNA metabolism. The DEAD-box putative RNA helicases are defined by nine highly conserved amino acid motifs, making specific targeting of selected members a challenging pharmacological problem. Eukaryotic initiation factor 4A (eIF4A) is the prototypical member of the DEAD-box family of RNA helicases. It is thought to utilize energy derived from ATP hydrolysis to unwind the mRNA structure downstream of the 5 0 cap structure, and, in conjunction with other translation factors, it prepares mRNA templates for ribosome recruitment during translation initiation. Pateamine, a natural product that selectively targets eIF4A and stimulates its RNA-binding properties, also inhibits translation initiation. Herein, we define pateamine's mode of action. Our data suggest a model whereby this natural product induces an engagement between eIF4A and RNA, rendering it unavailable to participate in the ribosome-recruitment phase of translation initiation. To our knowledge, pateamine is the first chemical inducer of dimerization that can force an interaction between an initiation factor (eIF4A) and RNA.
Experimental Procedures Plasmid Constructions
The plasmid pET3b/4A-GST was constructed as follows. The DraIII/ BamHI fragment of pET3b/4A [19] , corresponding to the C-terminal domain of mouse eIF4A, was amplified by PCR with oligonucleotides spanning these two sites. The oligonucleotide containing the BamHI site was designed to eliminate eIF4A's termination codon. The fragment generated was inserted in the DraIII/BamHI sites of pET3b/4A to generate pET3b/4A(2TGA). GST was amplified from pGEX-6P-1 with oligos containing BamHI sites, and the resulting GST tag was inserted in the BamHI site of pET3b/4A(2TGA), to create pET3b/ 4A-GST. The construction of pET(His 6 -eIF4B) has been previously reported [29] . Plasmids pMA311 and pMA312, which express GSTeIF4GI 688-1023 and GST-eIF4GI 1230-1600 , respectively, were a kind gift of Dr. S. Tahara (USC-Keck School of Medicine, LA).
Recombinant Proteins and Antibodies
His 6 -eIF4AI, eIF4AI-GST, His 6 -eIF4B, GST-eIF4GI 688-1023 , and GSTeIF4GI 1203-1600 were expressed in E. coli BL21 cells (Stratagene, Vancouver, BC) at 37 C up to an OD 600 of 0.8. After induction with 1 mM IPTG, cells were incubated at 30 C for an additional 3 hr before harvesting. His 6 -eIF4A was purified by Ni-NTA agarose and Q-Sepharose chromatography. eIF4AI-GST, GST-eIF4GI 688-1023 , and GST-eIF4GI 1203-1600 were purified on a glutathione column. His 6 -eIF4B was purified by Ni +2 -NTA agarose and heparin Sepharose chromatography.
The anti-eIF4A antibody (5D3) is a monoclonal antibody kindly provided by Dr. H. Trachsel (University of Berne, Berne, Switzerland) and has been previously described [30] . The anti-eIF4B and anti-YB-1 antibodies are rabbit polyclonal antibodies kindly provided by Dr. N. Sonenberg (McGill University, Montreal, Canada) [22, 31] . The anti-6xHis antibody was purchased from GE Healthcare BioSciences, Inc. (Baie d'Urfe, Quebec, Canada), the anti-eIF4E antibody was purchased from BD Biosciences (Mississauga, Ontario, Canada), the anti-eIF4GI antibody was obtained from Bethyl Laboratories, Inc. (Brockville, Ontario, Canada), and the anti-GST antibody was purchased from Santa Cruz (Santa Cruz, California).
GST and Poly(U) Affinity Capture Experiments
For GST affinity capture experiments involving eIF4A-GST and His 6 -eIF4B, 5 mg His 6 -eIF4B was incubated with 1 mM poly(U) RNA or RNA-11 (5 0 -GCUUUACGGUG-3 0 ) in binding buffer (20 mM HEPES [pH 7.5], 250 mM KOAc, 0.1% NP-40, 1 mM DTT) in the presence of 0.5% DMSO or 10 mM PatA in a 500 ml reaction at 4 C for 10 min. A total of 0.5 mg eIF4A-GST was then added, and the incubation continued for 1 hr. Where indicated, DNase-free RNase A was added, and the reactions were incubated at 37 C for 30 min. The same procedure as that described above was followed for the GST affinity capture experiments involving eIF4A and YB-1, except that 24 mg poly(A) + mRNA and 18 mg YB-1 were used instead of poly(U) and eIF4B, respectively. In experiments in which eIF4A-GST was preincubated with RNA-11, the preincubation reaction 3 and 6) . GST-eIF4GI fragments were purified by using glutathione beads, and eluted proteins were subjected to SDS-PAGE and western blotting, using a-GST (top panel) and a-eIF4A (bottom panel) antibodies. Lanes 1 and 4 lack input GST-eIF4GI. (C) PatA does not affect the interaction between eIF4A and eIF4GI, as assessed by time-resolved fluorescence resonance energy transfer. GST-eIF4GI fragments were incubated with His 6 -eIF4A, as well as with Eu-W1024-labeled anti-6xHis antibody and anti-GST IgG antibody conjugated to SureLight-Allophycocyanin, in the presence of 0.5% DMSO or 10 mM PatA. The fluorescence resonance energy transfer signal was monitored on an Analyst reader (LJL Biosystems) and represents the average of four experiments; standard error of the mean is shown. was performed at 4 C for 10 min before being added to the binding reaction. All reactions were then incubated for 1 hr at 4 C with glutathione Sepharose beads. Beads were washed with binding buffer, and proteins were eluted with 10 mM reduced glutathione, resolved on 10% SDS-polyacrylamide gels, and visualized by western blotting. For GST-eIF4GI and His 6 -eIF4A pull-down experiments, 0.5 mg GST-eIF4GI 688-1023 or GST-eIF4GI 1203-1600 was incubated with 0.2 mg His 6 -eIF4A in binding buffer in the presence of 0.5% DMSO or 10 mM PatA in a 25 ml reaction on ice for 30 min. Complexes were purified by using glutathione beads as described above. For poly(U) affinity capture experiments, 0.5 mg GST-eIF4GI 688-1023 or GST-eIF4GI 1203-1600 was incubated with 0.2 mg His 6 -eIF4A and poly(U) Sepharose in binding buffer in the presence of 0.5% DMSO or 10 mM PatA in a 50 ml reaction at 4 C for 1 hr. Beads were washed with binding buffer, and proteins were eluted with SDS sample buffer and were visualized by western blotting.
Chemical Crosslinking and Ribosome Binding
Procedures for chemical crosslinking and ribosome binding are described elsewhere [32] . Ribosome bindings were performed in rabbit reticulocyte lysates with 200,000 cpm (30 ng) input mRNA.
For chemical crosslinking of initiation factors to b-globin mRNA, 1 mg His 6 -eIF4B and His 6 -eIF4A were used. mRNA used in the ribosome-binding assay consisted of the first 200 nucleotides of b-globin, generated by in vitro transcription. m 7 GTP Affinity Capture Experiments Ribosomal salt wash was incubated with 1 mg His 6 -eIF4A and 0.5% DMSO or 10 mM PatA at 30 C for 1 hr. A total of 60 ml m 7 GTP-Sepharose beads was then added, and the reactions were incubated at 4 C for 2 hr. Beads were washed twice with 240 ml buffer A (20 mM HEPES [pH 7.5], 100 mM KCl, 0.2 mM EDTA) and twice with 240 ml 200 mM GDP, and proteins were eluted with 120 ml 200 mM GDP and then with 120 ml 200 mM m 7 GDP.
Time-Resolved Fluorescence Resonance Energy Transfer
His 6 -eIF4A (20 hM) and GST-eIF4GI 688-1023 (40 hM) or His 6 -eIF4A (100 hM) and GST-eIF4GI 1203-1600 (200 hM) were incubated with Eu-W1024-labeled anti-6xHis antibody (1 hM) (Perkin Elmer, Woodbrodge, Ontario, Canada) and anti-GST IgG antibody conjugated to SureLight-Allophycocyanin (100 hM) (Perkin Elmer, Woodbrodge, Ontario, Canada) in time-resolved fluorescence resonance energy Figure 6 . PatA Induces RNA-Mediated Sequestration of elF4A from elF4G (A) GST-tagged eIF4GI fragments were incubated with or without His 6 -eIF4A in the presence of 0.5% DMSO or 10 mM PatA. Pull-downs were performed with poly(U) Sepharose beads, and eluted proteins were resolved by SDS-PAGE and visualized by western blotting using a-eIF4A (top panel) and a-GST (bottom panel) antibodies.
(B) Effect of PatA on Jurkat cell polyribosomes. HeLa cells were exposed to 0.001% DMSO (vehicle) or 20 hM pateamine for 60 min. Cellular extracts were pretreated with micrococcal nuclease where indicated. Polyribosomes were analyzed on 10%-50% sucrose gradients, and fractions were collected from the gradients. (C) Western blots demonstrating the position of migration of eIF4A, eIF4E, and eIF4GI in fractions collected from untreated cells, cells exposed to PatA (20 hM), and cells exposed to PatA (20 hM) followed by micrococcal nuclease treatment (100 U/ml for 20 min at room temperature) of extracts.
transfer buffer (20 mM HEPES [pH 7.4], 10 mM KCl, 1 mM DTT, 0.015% Tween 20, 1 mg/ml IgG) in the presence of 0.5% DMSO or 10 mM PatA. Reactions were performed at room temperature for 3 hr. The fluorescence resonance energy transfer signal was monitored with an Analyst HT reader (LJL Biosystems).
NMR Spectroscopy
Expression and purification of uniformly labeled eIF4GII-m was described previously [11] . Protein was dialyzed into NMR buffer (50 mM Tris-HCl [pH 7.0], 150 mM NaCl, 5 mM DTT, 1 mM EDTA) and concentrated to 130 mM. PatA (10 mM stock solution in DMSO) was added in small aliquots to eIF4GII-m. The changes in binding after the addition of PatA and/or eIF4AI were recorded by 1 H-15 N HSQC spectra on a Varian Inova 500 MHz spectrometer equipped with a cryogenic probe.
Polysome Profiling
Jurkat cells (2 3 10 7 ) were incubated with 0.001% DMSO or 0.02 mM pateamine (dissolved in 0.001% DMSO) for 1 hr, after which the cells were collected by brief centrifugation. The cell pellets were resuspended in 500 ml lysis buffer (5 mM Tris [pH 7.5], 2.5 mM MgCl 2 , 1.5 mM KCl, 2 mM DTT, 1% Triton X-100, 0.5% sodium deoxycholate) in the presence of 100 mg/ml cycloheximide, were vortexed, and were centrifuged briefly. Where indicated, the supernatants were treated with micrococcal nuclease as follows. Lysates were supplemented with 1 mM CaCl 2 , 50 U micrococcal nuclease was added, and the reactions were incubated at room temperature for 20 min. The reactions were stopped by the addition of 2 mM EGTA. The lysates were loaded onto 10%-50% sucrose gradients and were centrifuged in a SW40 rotor at 35,000 rpm for 2 hr. Fractions were collected, and absorbance was monitored during the process. The fractions were then resolved on 10% SDS-PAGE gels, and proteins were visualized by western blotting with anti-eIF4A, anti-eIF4E, and anti-eIF4GI antibodies.
